676491-10-4

Basic information

• Product Name: 1-Piperidinecarboxylic acid, 4-(2-hydrazino-2-oxo-1-phenylethylidene)-, 1,1-dimethylethyl ester
• CAS NO: 676491-10-4
• Molecular Formula: C18H25N3O3
• Molecular Weight: 331.415
• Mol File: 676491-10-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1-Piperidinecarboxylic acid, 4-(2-hydrazino-2-oxo-1-phenylethylidene)-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Piperidinecarboxylic acid, 4-(2-hydrazino-2-oxo-1-phenylethylidene)-, 1,1-dimethylethyl ester(676491-10-4)
• EPA Substance Registry System: 1-Piperidinecarboxylic acid, 4-(2-hydrazino-2-oxo-1-phenylethylidene)-, 1,1-dimethylethyl ester(676491-10-4)

Safety Data

• Hazardous Substances Data: 676491-10-4(Hazardous Substances Data)

Upstream product

• 676491-09-1 4-(1-phenylmethylene-1-carboxylic acid)-piperidine-1-carboxylic acid tert-butyl ester 

Downstream Products

• 676491-14-8 4-[1-phenylmethylene-1-(5-methyl-1,3,4-oxadiazol-2-yl)]piperidine-1-carboxylic acid tert-butyl ester 
• 761446-23-5 4-[1-phenyl-1-(2-(N-(9-fluorenylmethoxycarbonyl)-3-azetidinecarbonyl)-hydrazinocarbonyl)-methylene]-piperidine-1-carboxylic acid tert-butyl ester 
• 676491-35-3 4-(1-phenylmethylene-1-(N'-hydroxymethylcarbonyl)carboxylhydrazide)-piperidine-1-carboxylic acid tert-butyl ester 
• 676491-31-9 4-(1-phenylmethylene-1-(N'-isobutyryl)carboxylhydrazide)-piperidine-1-carboxylic acid tert-butyl ester 
• 874947-19-0 4-[2-(N'-bromoacetyl-hydrazino)-2-oxo-1-phenyl-ethylidene]-piperidine-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

General synthesis of tetrasubstituted alkenyl-1,3,4-oxadiazoles

Tetrasubstituted alkenyl-1,3,4-oxadiazoles were synthesized in moderate to excellent yield, under mild conditions and in the presence of sensitive functional groups, via the cyclization of diacylhydrazides using PPh3 and hexachloroethane in the

Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides

This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with new piperidine 4-alkenyl derivatives that possess unique antiviral activity. More particularly, the present invention relates to compounds useful for the treatment of HIV and AIDS. The compounds of the invention for the general Formula I: wherein: Z is Q is selected from the group consisting of: —W— is